1349. Global Surveillance of Cefiderocol Against Gram-Negative Clinical Strains Collected in North America: SIDERO-WT-2015

BACKGROUND: Cefiderocol (CFDC) is a novel parenteral siderophore cephalosporin with potent activity against a wide range of Gram-negative pathogens, including carbapenem-resistant strains. Additionally, a recently conducted in vivo murine-based study has demonstrated an incremental exposure-response...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuji, Masakatsu, Hackel, Meredith, Echols, Roger, Yamano, Yoshinori, Sahm, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253188/
http://dx.doi.org/10.1093/ofid/ofy210.1180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253188/
http://dx.doi.org/10.1093/ofid/ofy210.1180

Ejemplares similares